These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29726068)

  • 21. Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis.
    Salagre E; Vizuete AF; Leite M; Brownstein DJ; McGuinness A; Jacka F; Dodd S; Stubbs B; Köhler CA; Vieta E; Carvalho AF; Berk M; Fernandes BS
    Eur Psychiatry; 2017 Jun; 43():81-91. PubMed ID: 28371745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.
    Girshkin L; Matheson SL; Shepherd AM; Green MJ
    Psychoneuroendocrinology; 2014 Nov; 49():187-206. PubMed ID: 25108162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural imaging biomarkers for bipolar disorder: Meta-analyses of whole-brain voxel-based morphometry studies.
    Lu X; Zhong Y; Ma Z; Wu Y; Fox PT; Zhang N; Wang C
    Depress Anxiety; 2019 Apr; 36(4):353-364. PubMed ID: 30475436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress markers in bipolar disorder: a meta-analysis.
    Andreazza AC; Kauer-Sant'anna M; Frey BN; Bond DJ; Kapczinski F; Young LT; Yatham LN
    J Affect Disord; 2008 Dec; 111(2-3):135-44. PubMed ID: 18539338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of MRS-quantified brain tissue lactate level in identifying children with mitochondrial disorders.
    Lunsing RJ; Strating K; de Koning TJ; Sijens PE
    Eur Radiol; 2017 Mar; 27(3):976-984. PubMed ID: 27271921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bias in emerging biomarkers for bipolar disorder.
    Carvalho AF; Köhler CA; Fernandes BS; Quevedo J; Miskowiak KW; Brunoni AR; Machado-Vieira R; Maes M; Vieta E; Berk M
    Psychol Med; 2016 Aug; 46(11):2287-97. PubMed ID: 27193198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial Biomarkers and Metabolic Syndrome in Bipolar Disorder.
    Zachos KA; Choi J; Godin O; Chernega T; Kwak HA; Jung JH; Aouizerate B; Aubin V; Bellivier F; Belzeaux-R R; Courtet P; Dubertret C; Etain B; Haffen E; Lefrere A A; Llorca PM; Olié E; Polosan M; Samalin L; Schwan R; Roux P; Barau C; Richard JR; Tamouza R; Leboyer M; Andreazza AC;
    Psychiatry Res; 2024 Sep; 339():116063. PubMed ID: 39003800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.
    Kubo H; Nakataki M; Sumitani S; Iga JI; Numata S; Kameoka N; Watanabe SY; Umehara H; Kinoshita M; Inoshita M; Tamaru M; Ohta M; Nakayama-Yamauchi C; Funakoshi Y; Harada M; Ohmori T
    J Affect Disord; 2017 Jan; 208():139-144. PubMed ID: 27770643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum folate levels in bipolar disorder: a systematic review and meta-analysis.
    Hsieh YC; Chou LS; Lin CH; Wu HC; Li DJ; Tseng PT
    BMC Psychiatry; 2019 Oct; 19(1):305. PubMed ID: 31640634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiponectin levels in patients with bipolar disorder: A systematic review and meta-analysis.
    Misiak B; Stramecki F; Kasznia J; Lis M; Stańczykiewicz B
    Psychoneuroendocrinology; 2019 Jun; 104():74-79. PubMed ID: 30818254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated CSF-lactate is a reliable marker of mitochondrial disorders in children even after brief seizures.
    Magner M; Szentiványi K; Svandová I; Ješina P; Tesařová M; Honzík T; Zeman J
    Eur J Paediatr Neurol; 2011 Mar; 15(2):101-8. PubMed ID: 21075023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review.
    Buoli M; Caldiroli A; Cumerlato Melter C; Serati M; de Nijs J; Altamura AC
    Psychiatry Clin Neurosci; 2016 Jun; 70(6):227-44. PubMed ID: 26969211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: a two-dimensional proton magnetic resonance spectroscopy study.
    Li H; Xu H; Zhang Y; Guan J; Zhang J; Xu C; Shen Z; Xiao B; Liang C; Chen K; Zhang J; Wu R
    Bipolar Disord; 2016 Nov; 18(7):583-590. PubMed ID: 27870506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder.
    Gallelli KA; Wagner CM; Karchemskiy A; Howe M; Spielman D; Reiss A; Chang KD
    Bipolar Disord; 2005 Dec; 7(6):589-97. PubMed ID: 16403184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating Oxidative Stress Markers in At-Risk Individuals for Bipolar Disorder: A Systematic Review and Meta-Analysis.
    Arat-Çelik HE; Eslami Abriz A; Coello K; Vinberg M; Ceylan D
    Neuropsychobiology; 2024; 83(3-4):121-134. PubMed ID: 39293410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of executive functioning deficits to N-acetyl aspartate (NAA) and gamma-aminobutyric acid (GABA) in youth with bipolar disorder.
    Huber RS; Kondo DG; Shi XF; Prescot AP; Clark E; Renshaw PF; Yurgelun-Todd DA
    J Affect Disord; 2018 Jan; 225():71-78. PubMed ID: 28800423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses.
    Bortolato B; Köhler CA; Evangelou E; León-Caballero J; Solmi M; Stubbs B; Belbasis L; Pacchiarotti I; Kessing LV; Berk M; Vieta E; Carvalho AF
    Bipolar Disord; 2017 Mar; 19(2):84-96. PubMed ID: 28470927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis.
    Fernandes BS; Gama CS; Ceresér KM; Yatham LN; Fries GR; Colpo G; de Lucena D; Kunz M; Gomes FA; Kapczinski F
    J Psychiatr Res; 2011 Aug; 45(8):995-1004. PubMed ID: 21550050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral and central glucose utilizations modulated by mitochondrial DNA 10398A in bipolar disorder.
    Li CT; Bai YM; Hsieh JC; Lee HC; Yang BH; Chen MH; Lin WC; Tsai CF; Tu PC; Wang SJ; Su TP
    Psychoneuroendocrinology; 2015 May; 55():72-80. PubMed ID: 25727318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging studies in early-onset bipolar disorder: a critical review.
    Frazier JA; Ahn MS; DeJong S; Bent EK; Breeze JL; Giuliano AJ
    Harv Rev Psychiatry; 2005; 13(3):125-40. PubMed ID: 16020026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.